Skip to main content
. 2024 Jan 5;9:10. doi: 10.1038/s41392-023-01687-y

Fig. 5.

Fig. 5

Inhibitors of the inflammasomes and inflammasome-related pathways. Distinct inhibitors target NLRP1, NLRP3, AIM2, ASC, caspase-1, interleukin-1β, interleukin-18, or GSDMD to inhibit the inflammasome activation and subsequent pyroptosis and cytokine release. The figure was created with the assistance of FIGDRAW